Treatment of ventricular arrhythmias by United States cardiologists: a survey before the Cardiac Arrhythmia Suppression Trial results were available.

[1]  R. Klein,et al.  Use of electrophysiologic testing in patients with nonsustained ventricular tachycardia: prognostic and therapeutic implications. , 1989, Journal of the American College of Cardiology.

[2]  Cardiac Arrhythmia Pilot Study Investigators.  Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: the CAPS. , 1988, The American journal of cardiology.

[3]  D. Wyse,et al.  A randomized clinical trial of the noninvasive and invasive approaches to drug therapy of ventricular tachycardia. , 1987, The New England journal of medicine.

[4]  S L Winters,et al.  A new noninvasive index to predict sustained ventricular tachycardia and sudden death in the first year after myocardial infarction: based on signal-averaged electrocardiogram, radionuclide ejection fraction and Holter monitoring. , 1987, Journal of the American College of Cardiology.

[5]  J. Morganroth.  Ambulatory electrocardiographic monitoring in the evaluation of new antiarrhythmic drugs. , 1986, Circulation.

[6]  S. Vlay.  How the university cardiologist treats ventricular premature beats: a nationwide survey of 65 University Medical Centers. , 1985, American heart journal.

[7]  W G Stevenson,et al.  Programmed electrical stimulation of the heart in patients with life-threatening ventricular arrhythmias: what is the significance of induced arrhythmias and what is the correct stimulation protocol? , 1985, Circulation.

[8]  D C Harrison,et al.  Antiarrhythmic drug classification: new science and practical applications. , 1985, The American journal of cardiology.

[9]  R. Peto,et al.  Beta blockade during and after myocardial infarction: an overview of the randomized trials. , 1985, Progress in cardiovascular diseases.

[10]  J. Morganroth.  Premature ventricular complexes. Diagnosis and indications for therapy. , 1984, JAMA.

[11]  R. Campbell,et al.  ORAL MEXILETINE IN HIGH-RISK PATIENTS AFTER MYOCARDIAL INFARCTION , 1980, The Lancet.

[12]  Parker Je.  Letter: Postoperative immunosuppression. , 1974 .

[13]  W. Rogers,et al.  Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. , 1989, The New England journal of medicine.

[14]  J. Bigger.  Identification of patients at high risk for sudden cardiac death. , 1984, The American journal of cardiology.

[15]  J. Morganroth.  Beta Blocking Agents in the Treatment of Ventricular Arrhythmias , 1982 .